Product Images Tadalafil

This is a description of a medication called Tadalafil. It appears to be manufactured by ECI Pharmaceuticals and comes in tablet form. The medication is meant for daily use and caution should be taken to ensure that the correct dosage is consumed. However, the rest of the text is difficult to understand as it contains errors from conversion.*

This is the label of a medication called Tadalafil tablets, USP, which is intended for daily use. The recommended dosage is not specified in the given text, but it instructs to avoid splitting the tablets and to take the entire dose at once.*

ECI Pharmaceuticals have manufactured TADALAFIL Controlled Form Tablets, USP. They come in a package of 30 tablets and are only available with a prescription. These tablets are intended for once-daily use, and the entire dose should be taken. It is advised not to split the tablets.*

This text appears to be a description of a medication called Tadalafil. It comes in tablet form and is meant for once-daily use. The text also contains warnings not to crush the tablets and to take the entire dose as prescribed.*

This text displays a graph showing the change from baseline in IPSS (International Prostate Symptom Score) total score for a clinical trial comparing Tadalafil Tablets 5mg to a placebo. The graph shows that there was a significant improvement in the IPSS total score for participants taking Tadalafil compared to the placebo group after 3 weeks of treatment, which continued throughout the 12-week duration of the study.*

This appears to be a section of a clinical study or a product label related to the treatment of benign prostatic hyperplasia (BPH) or erectile dysfunction using Tadalafil Tablets, with a focus on the IPSS Total Score, a standard measure for evaluating BPH symptoms. The table shows the total score and its components before and after treatment with Tadalafil and a placebo, along with significant differences between the two groups as indicated by *p<0.01, with the duration of treatment measured in weeks.*

This appears to be a comparison of the effectiveness of Tadalafil Tablets at a dosage of 5mg versus a placebo drug. The comparison is likely based on the IPSS Total Score which has been measured over the course of several weeks. The results show a statistically significant difference between Tadalafil and the placebo drug (indicated by *p<0.01).*

This is a table of readings for Systolic Blood Pressure (mmHg) taken at different time intervals after administering different doses of tadalafil and doxazosin. The text does not provide any additional information.*

This is a graph representing the Plasma Tadalafil Concentration (in ug/L) over time (in hours) after the administration of different doses of Tadalafil. The graph shows results for a single 20-mg dose, a single 5-mg dose, and a once-daily 5-mg dose given for 5 consecutive days.*